DLBCL
Advertisement
Robert E. Brown, MD, and collaborating researchers from the University of Texas Health Science Center at Houston McGovern ...
A study published in the Journal of Cancer Research and Clinical Oncology discussed outcomes of anti-CD20-based combination ...
Data on diffuse large B-cell lymphoma (DLBCL) from the OncoCollect Lymphoma group registry were recently published in ...
A study published in European Radiology examined the prognostic efficacy of automatic segmentation of diffuse large B-cell ...
According to a study published in the International Journal of Radiation Oncology, Biology, Physics, approximately 50% of ...
According to an article in Translational Cancer Research, data on the clinical outcomes of patients with primary diffuse ...
Recent first-line randomized controlled trials (RCTs) for patients with diffuse large B-cell lymphoma (DLCBL) have ...
Ferroptosis is an iron-dependent programmed cell death caused by lipid peroxidation; however, according to a study published ...
Noting that diffuse large B-cell lymphoma (DLBCL) generally occurs in elderly individuals, researchers Cancan Luo, Han Lie, ...
Citing an unmet clinical need in the identification and understanding of prognostic biomarkers for aggressive B-cell ...
In a study, published in Diagnostics, researchers evaluated whether fludeoxyglucose (FDG) positron emission tomography (PET) ...
Researchers, led by Jie Wang, MD, MS, conducted a network meta-analysis of randomized controlled trials to compare targeted ...
In a study published in the Journal of Oral Pathology & Medicine, researchers examined the prognostic value of varying ...
Examining Palliative Care Utilization Among Hospitalized Patients with Diffuse Large B-Cell Lymphoma
Noting a lack of data on palliative care in patients with diffuse large b-cell lymphoma (DLBCL), researchers, led by Inimfon ...
In a review of trials on the addition of molecular targeted agents (MTAs) to the rituximab, cyclophosphamide, ...
A study published in Leukemia & Lymphoma examined the prognostic potential of regulatory t-cells (Tregs) in patients with ...
The SADAL trial evaluated selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (RR DLBCL), and ...
Citing that current clinical variables used to determine prognosis in patients with diffuse large B-cell lymphoma (DLBCL) are ...
The phase II L-MIND study showed that tafasitamab (MOR208) combined with lenalidomide was clinically active and well ...
According to recent research, published in Frontiers in Cell and Developmental Biology, pyroptosis—an inflammatory ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.